Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of AbGn-168H Administered by Intravenous Infusion to Patients With Moderate to Severe Chronic Plaque Psoriasis (Randomised, Double-blind, Placebo-controlled)

NCT01855880 is registered in ClinicalTrials.gov with AbGenomics B.V Taiwan Branch as lead sponsor.

NCT NCT01855880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01855880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of AbGn-168H Administered by Intravenous Infusion to Patients With Moderate to Severe Chronic Plaque Psoriasis (Randomised, Double-blind, Placebo-controlled)
Lead sponsor
AbGenomics B.V Taiwan Branch
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2013
Completion date
March 31, 2014
Enrollment
54 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

moderate to severe chronic plaque psoriasis